CHELSEA CERVELLERA: Open Payments
NPI 1114379815 · OCALA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$235 in 12 payments from 9 companies in 2025. Trend: 2023 $2,385 · 2024 $2,039 · 2025 $235
Food & beverage: $235
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 3 | $59 |
| Novartis Pharmaceuticals Corporation | 2 | $34 |
| Merck Sharp & Dohme LLC | 1 | $24 |
| Eisai Inc. | 1 | $24 |
| UCB, Inc. | 1 | $23 |
| Daiichi Sankyo Inc. | 1 | $22 |
| Novo Nordisk Inc | 1 | $20 |
| AstraZeneca Pharmaceuticals LP | 1 | $14 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 1 | $14 |
Products named: LEQVIO, REPATHA, UPLIZNA, VERQUVO, Leqembi, Briviact, INJECTAFER, Wegovy.
Industry payments across FL — which companies pay providers there.
